Sanofi Ventures seals $625m fund boost amid sharp fall in biotech backing from VCs

The corporate venture capital arm of biopharma giant Sanofi has picked up another $625m multiyear capital commitment from its parent, increasing its total assets under management to more than $1.4bn.